'Why do children with cerebral palsy discontinue therapy with botulinum toxin A?' [5]

Daniel M. Weigl*, Nili Arbel

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)159-160
Number of pages2
JournalDevelopmental Medicine and Child Neurology
Issue number2
StatePublished - Feb 2007
Externally publishedYes

Cite this